Reported Nov 16, 2016 · Terminated
Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 24 patches Multi pack, Rx only, Marketed by Baxter Healthcare…
Sandoz Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Sandoz Inc · 100 College Rd W · Princeton, NJ · 08540-6604
Is this the product you have?
- Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 24 patches Multi pack, Rx only, Marketed by Baxter Healthcare Cop/Novartis, Deerfield, IL 60015
- Manufactured byAlza Corporation, Vacaville, CA 95688 for Novartis Consumer Health Inc., Parsippany, NJ 07054
- Lot codes and dates
5 of 5 products
Products covered by this recall # Product as published 1 NDC 10019-553-02 (24 ct. carton) and NDC 10019-553-88 (patch) 2 Lot #'s FV5908 and FX1520 both with expiry 06/2018 3 GB4910 and GC4210 both with expiry 09/2018 4 GE1927 with expiry 12/2018 5 GF7017 with expiry 01/2019 and GH8065 with expiry 02/2019. - Amount recalled
- 42,740 cartons (24 count carton from 7 total lots)
Where it was sold
Why it was recalled
Defective Delivery System; reports of damaged product that may alter the predicted release of scopolamine following transdermal application.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Sandoz Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.